Table 3.

Clinical characteristics of BAT positive patients and date-matched negative controls in cancer surveillance patients.

Characteristics	Cancer surveillance
	BAT negative (N=292)	BAT positive (N=146)	P Value
Female - no. (%)	136 (46.58%)	94 (64.38%)	0.0004
Age – years	45.67±10.62	43.70±13.38	0.1216
Age – tertiles			0.0085
<39.7 y - no. (%)	80 (27.40%)	59 (40.41%)
39.7–50.7 y - no. (%)	75 (25.68%)	33 (22.60%)
>50.7 y - no. (%)	137 (46.92%)	54 (36.99%)
BMI - kg/m2	24.27±3.39	21.00±2.43	<0.0001
BMI – tertiles			<0.0001
<21.5 kg/m2 - no. (%)	64 (21.92%)	88 (60.27%)
21.5–24.7 kg/m2 - no. (%)	97 (33.22%)	52 (35.62%)
>24.7 kg/m2 - no. (%)	131 (44.86%)	6 (4.11%)
Glucose - mmol/l	5.23±0.98	4.99±0.50	0.0011
Glucose – tertiles			0.2337
<4.8 mmol/l - no. (%)	94 (32.87%)	47 (33.57%)
4.8–5.3 mmol/l - no. (%)	68 (23.78%)	46 (32.86%)
>5.3 mmol/l - no. (%)	124 (43.36%)	47 (33.57%)